BRC Stock Analysis: Brady | NYSE

Safety Signs, Identification Labels, Printing Systems, Healthcare Wristbands

Total Rating 57

Safety 85

Buy Signal -0.35

Security & Protection Services
Industry Rotation: +2.5

Market Cap: 3.94B
Avg Turnover: 22.3M

Risk 3d forecast

Volatility23.7%

VaR 5^th Pctl3.96%

VaR vs Median1.47%

Reward TTM

Sharpe Ratio0.34

Rel. Str. IBD38

Rel. Str. Peer Group33.6

Character TTM

Beta0.729

Beta Downside0.771

Hurst Exponent0.457

Drawdowns 3y

Max DD26.12%

CAGR/Max DD0.65

CAGR/Mean DD3.17

EPS (Earnings per Share)

EPS CAGR: 11.54%
EPS Trend: 99.2%

Last SUE: 0.18
Qual. Beats: 0

Revenue

Rev. CAGR: 9.00%
Rev. Trend: 97.7%

Last SUE: 0.79
Qual. Beats: 0

Warnings

Choppy

Below Avwap Earnings

Below Sma 200d

Tailwinds

Confidence

Seasonality 11.7 years of data

Jan +0.5% 8

Feb +2.0% 5

Mar -1.7% 19

Apr -0.5% 20

May +3.1% 18

Jun -2.2% 30

Jul +0.8% 22

Aug -0.1% 7

Sep +0.3% 13

Oct -2.1% 26

Nov +4.7% 45

Dec +0.1% 15

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: BRC Brady

Brady Corporation is a global manufacturer of identification solutions and workplace safety products, serving customers across the Americas, Asia, Europe, and Australia. Its product portfolio spans safety and traffic signs, floor-marking tapes, pipe markers, lockout/tagout devices, spill control, personal protection equipment, and first aid supplies, along with labeling systems, RFID and barcode scanners, engraving equipment, and asset tracking tags for industrial applications. The company also supplies healthcare-oriented products such as patient wristbands and labels, as well as ID badging, lanyards, and access control systems.

Brady serves a highly diversified end-market base, including industrial and electronic manufacturing, healthcare, chemical, oil and gas, alternative energy, automotive, aerospace, government, mass transit, construction, utilities, education, retail, and telecommunications. The company distributes through multiple channels-a network of distributors, a direct sales force, and digital/e-commerce platforms. Brady was incorporated in 1914 and is headquartered in Milwaukee, Wisconsin.

Within the broader market classification, Brady is categorized under the Industrials sector and the Commercial Printing sub-industry (GICS), reflecting the labeling and printed identification nature of much of its core product line. Its business model combines physical product manufacturing with recurring software and service offerings for safety compliance auditing, procedure writing, and training, which support customer retention across regulated industries.

Headlines to Watch Out For

Industrial manufacturing cycle drives identification product demand
Pricing actions and productivity lift operating margins
Acquisitions expand identification and traceability portfolio

Piotroski VR-10 (Strict) 8.5

Net Income: 205.4m TTM > 0 and > 6% of Revenue
FCF/TA: 0.10 > 0.02 and ΔFCF/TA 1.54 > 1.0
NWC/Revenue: 20.04% < 20% (prev 19.26%; Δ 0.78% < -1%)
CFO/TA 0.13 > 3% & CFO 244.1m > Net Income 205.4m
Net Debt (-34.9m) to EBITDA (314.0m): -0.11 < 3
Current Ratio: 1.94 > 1.5 & < 3
Outstanding Shares: last quarter (47.8m) vs 12m ago -0.06% < -2%
Gross Margin: 51.75% > 18% (prev 50.27%; Δ 1.48% > 0.5%)
Asset Turnover: 92.66% > 50% (prev 87.28%; Δ 5.39% > 0%)
Interest Coverage Ratio: 27.75 > 6 (EBIT TTM 269.1m / Interest Expense TTM 9.70m)

Altman Z'' 7.67

A: 0.18 (Total Current Assets 688.5m - Total Current Liabilities 355.5m) / Total Assets 1.85b
B: 0.80 (Retained Earnings 1.48b / Total Assets 1.85b)
C: 0.15 (EBIT TTM 269.1m / Avg Total Assets 1.79b)
D: 2.75 (Book Value of Equity 1.36b / Total Liabilities 494.4m)
Altman-Z'' = 7.67 = AAA

Beneish M -2.99

DSRI: 1.02 (Receivables 260.9m/231.9m, Revenue 1.66b/1.51b)
GMI: 0.97 (GM 50.27% / 51.75%)
AQI: 0.95 (AQ_t 0.45 / AQ_t-1 0.48)
SGI: 1.10 (Revenue 1.66b / 1.51b)
TATA: -0.02 (NI 205.4m - CFO 244.1m) / TA 1.85b)
Beneish M = -2.99 (Cap -4..+1) = A

What is the price of BRC shares?

As of September 27, 2026, the stock is trading at USD 84.02 with a total of 275,571 shares traded. Over the past week, the price has changed by -0.10%, over one month by -10.25%, over three months by -6.01% and over the past year by +10.66%.

Current recommended Stop Loss: 78.40 (which is 6.7% or 2.5 ATR below the current price).

Is BRC a buy, sell or hold?

Brady has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy BRC.

StrongBuy: 2
Buy: 0
Hold: 0
Sell: 0
StrongSell: 0

What are the forecasts/targets for the BRC price?

Analysts Target Price	110	30.9%

Brady (BRC) - Fundamental Data Overview as of 20 September 2026

Market Cap USD = 3.94b (3.94b USD * 1.0 USD.USD)
P/E Trailing = 19.5581
P/E Forward = 15.361
P/S = 2.3738
P/B = 2.9441
P/EG = 1.6733
Revenue TTM = 1.66b USD
EBIT TTM = 269.1m USD
EBITDA TTM = 314.0m USD
Long Term Debt = 15.0m USD (from longTermDebt, last quarter)
Short Term Debt = 17.0m USD (from shortTermDebt, last quarter)
Debt = 152.2m USD (from shortLongTermDebtTotal, last quarter) + Leases 68.6m
Net Debt = -34.9m USD (calculated: Debt 152.2m - CCE 187.1m)
Enterprise Value = 3.91b USD (3.94b + Debt 152.2m - CCE 187.1m)
Interest Coverage Ratio = 27.75 (Ebit TTM 269.1m / Interest Expense TTM 9.70m)
EV/FCF = 20.29x (Enterprise Value 3.91b / FCF TTM 192.7m)
FCF Yield = 4.93% (FCF TTM 192.7m / Enterprise Value 3.91b)
FCF Margin = 11.59% (FCF TTM 192.7m / Revenue TTM 1.66b)
Net Margin = 12.36% (Net Income TTM 205.4m / Revenue TTM 1.66b)
Gross Margin = 51.75% ((Revenue TTM 1.66b - Cost of Revenue TTM 801.7m) / Revenue TTM)
Gross Margin QoQ = 52.90% (prev 51.80%)
Tobins Q-Ratio = 2.11 (Enterprise Value 3.91b / Total Assets 1.85b)
Interest Expense / Debt = 6.37% (Interest Expense 9.70m / Debt 152.2m)
Taxrate = 20.83% (54.0m / 259.4m)
NOPAT = 213.1m (EBIT 269.1m * (1 - 20.83%))
Current Ratio = 1.94 (Total Current Assets 688.5m / Total Current Liabilities 355.5m)
Debt / Equity = 0.11 (Debt 152.2m / totalStockholderEquity, last quarter 1.36b)
Debt / EBITDA = -0.11 (Net Debt -34.9m / EBITDA 314.0m)
Debt / FCF = -0.18 (Net Debt -34.9m / FCF TTM 192.7m)
Total Stockholder Equity = 1.31b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.45% (Net Income 205.4m / Total Assets 1.85b)
RoE = 15.62% (Net Income TTM 205.4m / Total Stockholder Equity 1.31b)
RoCE = 20.24% (EBIT 269.1m / Capital Employed (Equity 1.31b + L.T.Debt 15.0m))
RoIC = 14.90% (NOPAT 213.1m / Invested Capital 1.43b)
WACC = 8.42% (E(3.94b)/V(4.10b) * Re(8.55%) + D(152.2m)/V(4.10b) * Rd(6.37%) * (1-Tc(0.21)))
Discount Rate = 8.55% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -85.65 | Cagr: -0.59%
[DCF] Terminal Value 77.74% ; FCFF base≈177.0m ; Y1≈202.9m ; Y5≈298.7m
[DCF] Fair Price = 103.2 (EV 4.44b - Net Debt -34.9m = Equity 4.48b / Shares 43.4m; r=8.42% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 99.16 | EPS CAGR: 11.54% | SUE: 0.18 | # QB: 0
Revenue Correlation: 97.69 | Revenue CAGR: 9.00% | SUE: 0.79 | # QB: 0
EPS current Quarter (2026-10-31): EPS=1.51 | Chg30d=+16.15% | Revisions=+40% | Analysts=2
EPS next Quarter (2027-01-31): EPS=1.43 | Chg30d=+6.34% | Revisions=+25% | Analysts=2
EPS current Year (2027-07-31): EPS=6.55 | Chg30d=+7.55% | Revisions=+25% | GrowthEPS=+23.8% | GrowthRev=+74.0%
EPS next Year (2028-07-31): EPS=7.21 | Chg30d=+4.87% | Revisions=+25% | GrowthEPS=+10.2% | GrowthRev=+3.8%
[Analyst] Revisions Ratio: +62% (up=5, down=0)